Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-09-16 Sale |
2022-09-20 6:00 pm |
Iterum Therapeutics plc | ITRM | Ahrens Brenton Karl Director |
37,246 | $1.8238 | $67,930 | 410 (Indirect Direct) |
View |
| 2022-09-13 Sale |
2022-09-15 5:36 pm |
Iterum Therapeutics plc | ITRM | Ahrens Brenton Karl Director |
45,000 | $2.0855 | $93,846 | 37,656 (Indirect Direct) |
View |
| 2022-09-08 Sale |
2022-09-12 9:01 pm |
Iterum Therapeutics plc | ITRM | Ahrens Brenton Karl Director |
33,298 | $2.3065 | $76,803 | 82,656 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-12-23 Option Award |
2022-12-28 9:00 pm |
N/A 2032-12-22 |
Iterum Therapeutics plc | ITRM | Ahrens Brenton Karl Director |
29,125 | $0.81 | 29,125 (Direct) |
View |
| 2022-09-25 Option Award |
2022-09-28 06:12 am |
N/A 2032-09-24 |
Iterum Therapeutics plc | ITRM | Ahrens Brenton Karl Director |
14,838 | $1.59 | 14,838 (Direct) |
View |
| 2022-06-25 Option Award |
2022-06-28 9:00 pm |
N/A 2032-06-24 |
Iterum Therapeutics plc | ITRM | Ahrens Brenton Karl Director |
113,276 | $0 | 113,276 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 5:01 pm |
N/A 2032-06-14 |
Iterum Therapeutics plc | ITRM | Ahrens Brenton Karl Director |
647,059 | $0 | 647,059 (Direct) |
View |
| 2022-03-25 Option Award |
2022-03-29 8:00 pm |
N/A 2032-03-26 |
Iterum Therapeutics plc | ITRM | Ahrens Brenton Karl Director |
47,436 | $0 | 47,436 (Direct) |
View |
| 2021-06-23 Option Award |
2021-06-25 4:05 pm |
N/A 2031-06-22 |
Iterum Therapeutics plc | ITRM | Ahrens Brenton Karl Director |
64,706 | $0 | 64,706 (Direct) |
View |